| 摘要: |
| 新时代以来,我国药品监管政务新媒体建设在取得一定成果的同时,也面临着权威性与传播力难以兼容的二元困境,从根本上限制了药品监管政务新媒体的长远发展。针对这一问题,以“中国药闻”为典型的药品监管政务新媒体品牌,通过构建“平台差异化布局、系统层级化联动、分众化传播”的三维传播体系,达成了行政与社会资源的有效整合、权威信息的广泛传播以及科普知识的精准触达,探寻出一条解决上述困境的实践路径,为提升药品监管传播效能提供了经验参考。 |
| 关键词: 药品监管 政务新媒体 中国药闻 传播矩阵 |
| DOI:10.13506/j.cnki.jpr.2026.09.008 |
| 基金项目: |
|
Received Date:May 29, 2026
Revision Date:July 20, 2026
Publication Date:September 30, 2026
|
|
| Research on strategies for balancing authority and communication reach in government new media for drug regulation: A case study of "Chinese Pharmaceutical News" |
| ZHANG Yu |
| (News and Publicity Center,National Medical Products Administration,Beijing 100037,China) |
| Abstract: |
| Ever since the new era started, China has made significant progress in the development of government new media for drug regulation. These platforms continue to face a structural dilemma in which authority and communication reach are often difficult to reconcile. This kind of tension fundamentally limits the sustainable growth of government new media in the drug regulation area. In response to this challenge, government new media brands for drug regulation, represented by "Chinese Pharmaceutical News", have developed a three-dimensional communication system featuring differentiated platform deployment, hierarchical system-wide coordination, and audience-oriented integrated communication. This system has effectively integrated administrative and social resources, expanded the dissemination of authoritative information, and enabled the precise delivery of science popularization content. It offers a practical pathway for resolving the tension between authority and communication reach and provides useful experience for improving the effectiveness of pharmaceutical regulatory communication. |
| Key words: Drug regulation Government new media Chinese Pharmaceutical News Communication matrix |